Full-Life Technologies

Full-Life Technologies Limited is a global radiotherapeutics company headquartered in Shanghai, China, with operations in Belgium, Germany, and China. The company focuses on developing radiopharmaceutical treatments intended to deliver therapeutic payloads directly to tumors, reflecting its mission to help patients move “from half-life to full-life.” Its approach combines a radionuclide with a targeting vector, such as a peptide, small molecule, or single-domain antibody, to direct the payload toward the tumor.

Full-Life’s work spans radio-therapeutic discovery and development, supported by an integrated platform for radiopharmaceutical production and logistics. The company also describes its activities through a pipeline of programs and a radio technology platform, alongside manufacturing and partnering capabilities. Its team brings experience across the discovery, development, production, and logistics of radiopharmaceuticals. Full-Life shares company news and research updates, including presentations on candidates such as FL-031 and FL-801. Through its integrated capabilities, the company aims to advance radiotherapeutic programs and support the delivery of radiopharmaceutical drug products.